From the Wall Street Journal:
Big Pharma Needs to Get Busy in the Lab
Blanket generalizations about biotech firms being more efficient are unfounded.
[I didn't link to the the Streetwalker's come on because she showed only a fat, hairy leg. Even the dumbest capitalist should be aware that innovation comes from the bottom. Invention is most decidedly messy. It is the polar opposite of efficiency, its illegitimate offspring.]
I would guess there might already be recriminations at J&J for making a hefty bet on crippled bulldog Aduro in a race against a healthy greyhound. No way of knowing unless the fancy executive suite springs a leak and there is always the remote possibility the bulldog can win.
As always JMO.
Best, Terry